Sandoz Group AG

BATS-CHIXE:SDZZ Stock Report

Market Cap: CHF 28.1b

Sandoz Group Valuation

Is SDZZ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SDZZ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: SDZZ (CHF65.12) is trading below our estimate of future cash flow value (CHF99.1)

Significantly Below Future Cash Flow Value: SDZZ is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SDZZ?

Key metric: As SDZZ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SDZZ. This is calculated by dividing SDZZ's market cap by their current earnings.
What is SDZZ's PE Ratio?
PE Ratio37.6x
EarningsUS$914.00m
Market CapUS$34.35b

Price to Earnings Ratio vs Peers

How does SDZZ's PE Ratio compare to its peers?

The above table shows the PE ratio for SDZZ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average17.7x
HLN Haleon
20.1x6.26%UK£33.6b
GSK GSK
13.9x5.13%UK£80.8b
HIK Hikma Pharmaceuticals
11.2x7.43%UK£3.4b
AZN AstraZeneca
25.5x13.77%UK£200.7b
SDZZ Sandoz Group
37.6x17.14%CHF 28.1b

Price-To-Earnings vs Peers: SDZZ is expensive based on its Price-To-Earnings Ratio (37.6x) compared to the peer average (17.7x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does SDZZ's PE Ratio compare vs other companies in the European Pharmaceuticals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
No. of Companies8PE01632486480+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SDZZ is expensive based on its Price-To-Earnings Ratio (37.6x) compared to the European Pharmaceuticals industry average (21.4x).

Price to Earnings Ratio vs Fair Ratio

What is SDZZ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SDZZ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio37.6x
Fair PE Ratio34.1x

Price-To-Earnings vs Fair Ratio: SDZZ is expensive based on its Price-To-Earnings Ratio (37.6x) compared to the estimated Fair Price-To-Earnings Ratio (34.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SDZZ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 65.12
CHF 71.33
+9.53%
12.74%CHF 83.47CHF 52.98n/a16
Jul ’27CHF 71.60
CHF 71.61
+0.014%
12.60%CHF 86.83CHF 54.29n/a16
Jun ’27CHF 64.16
CHF 67.22
+4.77%
16.21%CHF 84.39CHF 45.51n/a17
May ’27CHF 62.48
CHF 66.47
+6.39%
15.88%CHF 80.13CHF 45.23n/a17
Apr ’27CHF 63.88
CHF 66.71
+4.44%
15.97%CHF 81.63CHF 45.98n/a17
Mar ’27CHF 67.86
CHF 61.53
-9.32%
17.24%CHF 80.99CHF 44.48n/a16
Feb ’27CHF 61.12
CHF 56.66
-7.30%
15.38%CHF 70.90CHF 43.93n/a16
Jan ’27CHF 57.82
CHF 53.84
-6.89%
9.53%CHF 64.97CHF 45.64n/a15
Dec ’26CHF 56.56
CHF 52.63
-6.95%
10.30%CHF 60.87CHF 44.77n/a14
Nov ’26CHF 53.37
CHF 50.94
-4.56%
10.69%CHF 57.39CHF 38.22n/a14
Oct ’26CHF 44.72
CHF 49.23
+10.08%
12.54%CHF 59.52CHF 37.35n/a14
Sep ’26CHF 50.06
CHF 49.40
-1.32%
12.46%CHF 60.57CHF 38.02n/a14
Aug ’26CHF 46.83
CHF 45.88
-2.03%
14.43%CHF 61.47CHF 36.14n/a14
Jul ’26CHF 42.89
CHF 43.12
+0.53%
13.07%CHF 53.90CHF 34.03CHF 71.6015
Jun ’26CHF 41.35
CHF 44.58
+7.81%
13.55%CHF 56.59CHF 34.89CHF 64.1615
May ’26CHF 35.69
CHF 43.57
+22.08%
13.67%CHF 55.72CHF 34.24CHF 62.4815
Apr ’26CHF 36.30
CHF 45.17
+24.46%
11.91%CHF 56.71CHF 38.11CHF 63.8815
Mar ’26CHF 39.53
CHF 44.33
+12.13%
12.87%CHF 58.04CHF 35.21CHF 67.8615
Feb ’26CHF 43.61
CHF 44.47
+1.97%
13.15%CHF 56.93CHF 35.81CHF 61.1215
Jan ’26CHF 36.97
CHF 43.82
+18.54%
12.43%CHF 56.38CHF 36.25CHF 57.8215
Dec ’25CHF 39.96
CHF 41.78
+4.56%
9.32%CHF 50.26CHF 35.63CHF 56.5614
Nov ’25CHF 40.08
CHF 41.32
+3.08%
10.30%CHF 50.78CHF 33.44CHF 53.3714
Oct ’25CHF 35.31
CHF 38.78
+9.84%
11.01%CHF 47.91CHF 31.34CHF 44.7215
Sep ’25CHF 37.55
CHF 37.61
+0.15%
12.73%CHF 47.96CHF 31.37CHF 50.0615
Aug ’25CHF 38.21
CHF 36.59
-4.24%
12.75%CHF 44.91CHF 27.52CHF 46.8315
Jul ’25CHF 32.44
CHF 36.51
+12.55%
11.63%CHF 43.62CHF 27.88CHF 42.8914
CHF 71.42
Fair Value
8.8% undervalued intrinsic discount
16
Number of Analysts

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/28 08:23
End of Day Share Price 2026/07/28 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sandoz Group AG is covered by 36 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Emily FieldBarclays
James GordonBarclays
Sidhartha ModiBarclays